Pregled bibliografske jedinice broj: 1022473
Nanotechnology Approaches for Autologous Stem Cell Manipulation in Personalized Regenerative Medicine
Nanotechnology Approaches for Autologous Stem Cell Manipulation in Personalized Regenerative Medicine // Personalized Medicine in Healthcare Systems, Europeanization and Globalization / Bodiroga-Vukobrat, Nada ; Rukavina, Daniel ; Pavelić, Krešimir ; Sander, Gerald G. (ur.).
Cham: Springer, 2019. str. 45-54 doi:10.1007/978-3-030-16465-2_4
CROSBI ID: 1022473 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Nanotechnology Approaches for Autologous Stem
Cell
Manipulation in Personalized Regenerative
Medicine
Autori
Ban, Jelena ; Mladinić Pejatović, Miranda
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, znanstveni
Knjiga
Personalized Medicine in Healthcare Systems, Europeanization and Globalization
Urednik/ci
Bodiroga-Vukobrat, Nada ; Rukavina, Daniel ; Pavelić, Krešimir ; Sander, Gerald G.
Izdavač
Springer
Grad
Cham
Godina
2019
Raspon stranica
45-54
ISBN
978-3-030-16464-5
Ključne riječi
stem cells ; nanotechnology ; personalized medicine
Sažetak
Personalized medicine is a new interdisciplinary approach, focused on the development of patient-specific therapies, which considers the fact that every person has unique genetic and physiological characteristics. Modern bionanotechnological procedures are used in personalized medicine mostly to allow the identification of a person’s genetic profile, but also to develop new diagnostic and therapeutic tools and procedures. Stem cells are a promising source of donor cells in regenerative medicine. In particular, induced pluripotent stem cells (iPSCs) represent a unique opportunity for self- therapies in a personalized approach. They can be derived from the patient’s somatic cells, such as fibroblasts, by the reprogramming process and successively differentiated in vitro into a required cell type, to be finally transplanted back into the patient. This autologous therapy eliminates the possibility of rejection and is ethically acceptable because it does not require manipulation of human embryos. Several disease- specific human iPSCs have been produced since their discovery, but also some serious problems have emerged. In this chapter we will describe how nanotechnological approaches, such as the use of nanoparticles (NPs) and nanostructured materials, can contribute in overcoming these obstacles to allow clinical applications of iPSCs.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Biotehnologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Sveučilište u Rijeci - Odjel za biotehnologiju